Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rheopheresis Mechanism of Action and Impacts on the Evolution of Peripheral Arterial Disease in Hemodialysis Patients

NCT05373524 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT05373524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05373524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rheopheresis Mechanism of Action and Impacts on the Evolution of Peripheral Arterial Disease in Hemodialysis Patients
Lead sponsor
University Hospital, Grenoble
Phase
Not applicable
Overall status
Unknown status
Start date
June 30, 2022
Completion date
May 31, 2024
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemodialysis